Proteolysis-focusing on chimeras (PROTACs) and molecular glue degraders (MGDs) are quite possibly the most maturely made TPD tactics. On this critique, we target both equally preclinical experiments and scientific trials to offer a comprehensive summary of the security and medical efficiency of PROTACs and MGDs in hematologic malignancies over the